Skip to content

Clinical trials

Observational Lysosomal Storage Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Phase: Observational Country / region: United Kingdom Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20111
20151
20191
20201
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.1
Azafaros B.V.1
BioMarin Pharmaceutical1
Denali Therapeutics Inc.1
JCR Pharmaceuticals Co., Ltd.1
Shire1
University of Pennsylvania1
ZevraDenmark1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases8
Gangliosidosis, GM12
Genetic Diseases, Inborn2
Mucopolysaccharidosis II2
Sudden Infant Death2
Brain Diseases, Metabolic, Inborn1
Carbohydrate Metabolism, Inborn Errors1
Cholesterol Ester Storage Disease1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1
Fucosidosis1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.